David Grainger

Prior to co-founding Medicxi Ventures, David was a venture partner with Index Ventures for four years, having joined the life sciences team in 2012.On behalf of Index, David co-founded Epsilon-3 Bio, Methusalah Health, and XO1 (acquired by Janssen Pharmaceuticals) among other companies. Before joining Index, he founded Funxional Therapeutics and